NASDAQ: ALVRAllovir Inc Stock
$8.18-0.39 (-4.55%)
Updated Aug 16, 2022
ALVR Price
$8.18
Fair Value Price
$9.28
Market Cap
$761.26M
52 Week Low
$3.17
52 Week High
$26.41
P/E
-2.71x
P/B
4.81x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$191.95M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.27
Operating Cash Flow
-$140M
Beta
1.58
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ALVR Overview
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ALVR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ALVR ($8.18) is undervalued by 11.88% relative to our estimate of its Fair Value price of $9.28 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ALVR ($8.18) is not significantly undervalued (11.88%) relative to our estimate of its Fair Value price of $9.28 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ALVR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ALVR due diligence checks available for Premium users.
ALVR News
Valuation
ALVR fair value
Fair Value of ALVR stock based on Discounted Cash Flow (DCF)
Price
$8.18
Fair Value
$9.28
Undervalued by
11.88%
ALVR ($8.18) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ALVR ($8.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ALVR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ALVR price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.71x
Industry
15.64x
Market
32.28x
ALVR price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.81x
Industry
4.91x
ALVR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ALVR's financial health
Profit margin
Revenue
$0.0
Net Income
-$44.6M
Profit Margin
0%
ALVR's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$200.0M
Liabilities
$41.9M
Debt to equity
0.27
ALVR's short-term assets ($176.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ALVR's short-term assets ($176.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ALVR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$28.9M
Investing
-$479.0k
Financing
$244.0k
ALVR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ALVR vs Biotech Stocks
Allovir Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.